AlphAIalphai — Financial news for AI agents
yahoo.comSEP 62 min read$SIGA

SIGA Tech (SIGA): Profits Drop 65%, But Cash and Special Payouts Remain

SIGA Technologies (SIGA) reported a 65% profit drop year-over-year, with Q2 revenue at $41M and net income at $12.5M. The company completed a major government contract and paid a $0.6 special dividend. Despite declines, SIGA remains profitable and diversifies its customer base.

Original reporting
yahoo.com
Published Sep 6, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 6, 2026, 1:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
SIGA Tech (SIGA): Profits Drop 65%, But Cash and Special Payouts Remain — source image
Source · yahoo.com
Decision brief

The 30-second read

$SIGABearishMed
01

Why it matters

The earnings release highlights a significant revenue decline as the legacy 19C contract ends, but the company remains profitable and returns cash to shareholders.

02

Market read

First‑time earnings disclosure for SIGA Q2 2026, providing fresh data on revenue, profit, and dividend, relevant for biotech and government‑contract investors.

03

What to watch

International oral TPOXX sales and potential new government orders could offset the decline in legacy contract revenue.

Relevance 6/10Novelty 6/10Timing: post‑market earnings release

Background

SIGA Technologies (NASDAQ:SIGA) focuses on antiviral products, primarily TPOXX, sold to the U.S. Strategic National Stockpile and international customers.

Company-level read

Ticker impact

$SIGABearishMedium confidence
Context

SIGA Technologies reported Q2 earnings with profit of $12.5M, revenue down 50% YoY, and a special dividend of $0.6 per share.

Expected impact

Potential short-term downside pressure with limited upside unless new contract pipeline is confirmed.

Evidence & confidence

Revenue and earnings fell sharply year-over-year, indicating weaker demand, while the special dividend suggests cash strength but may not offset the earnings weakness.

Market effects

Sector

Biotech firms reliant on government contracts may see similar earnings pressure as contracts wind down.

Regional

U.S. biotech sector may experience modest pullback.

Global

Limited to investors tracking niche biotech and government‑contract exposure.

Counterpoint

What could challenge this read

The special dividend and completion of the 19C contract could signal a turning point, offering a buying opportunity at lower valuations.

Key entities

  • company
    SIGA Technologies

    Biotech firm producing TPOXX antiviral medication.

  • government_entity
    U.S. Strategic National Stockpile

    Major buyer of SIGA's IV TPOXX product.

Read at source← All news

Related articles

AUG 14
$SIGAMed

SIGA (SIGA) Q2 2026 Earnings Call Transcript

SIGA Technologies reported Q2 2026 results in an earnings call. Total revenue fell to $41.0M from $81.1M due to delivery timing. Operating income was $13.9M and net income $12.5M, with diluted EPS $0.17. Cash was $117.6M, zero debt. Management said the final IV TPOXX order under the 19C contract was completed and a new U.S. contract is targeted after slower HHS transitions.

fool.com6 min
AUG 6
$SIGAMed

SIGA TECHNOLOGIES INC (SIGA): Results of Operations and Financial Condition

SIGA TECHNOLOGIES INC (SIGA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026 • $37 Million of TPOXX Sales Generated in the Second Quarter • Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, August 6, 2026 (GLOBENEWSWIRE) -- SIGA Technologies, Inc. (SIGA)

SEC EDGAR 8-K4 min
JUL 27
$SIGAMedAI 8/10

Sigma Advanced Systems Secures USD 104.9 Million Export Order for Next-generation Extended Range 155mm Base Bleed Artillery Shells

Sigma Advanced Systems said it won a USD 104.9 million export order from a North American customer to manufacture and supply 147,000 units of 155mm base bleed artillery shell bodies over the next 6 to 12 months. The company cited prior contracts for 155mm fuzes and M107 shell bodies and said the shells reduce drag to extend range. Sigma shares last traded at Rs. 521.45 on BSE.

equitybulls.com4 min
SEP 7
$TGTHighAI 8/10

Target's Non-Merchandise Sales Jump 20% as New Revenue Streams Scale

Target Corporation reported a 5.3% year-over-year increase in total net sales to $26.54 billion for Q2 2026, with non-merchandise sales surging 20.1%. Growth was driven by Roundel advertising, Target Circle 360 memberships, and Target+ marketplace. Advertising revenues rose to $279 million, while other revenues increased to $174 million. The company's shares have risen 32.7% over the past three months, outperforming industry peers.

finance.yahoo.com2 min
SEP 7
$DELLHighAI 9/10

Evercore ISI Names Top Pick, Lifts Target to $575 on AI Growth

Evercore ISI kept Dell Technologies as a Top Pick with an Outperform rating and a $575 price target, despite removing it from its Tactical Outperform list. Dell reported July-quarter sales of $47B and EPS of $7.04, beating estimates. Revenue grew 58% YoY, driven by AI and traditional server demand. Dell raised FY27 revenue guidance to $192B and EPS to $25.50. Evercore ISI cited supply constraints as supportive of sustained growth.

investing.com2 min